| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| Capital Gains | 2019-12 | Purchase | 2020-12 | 54,064 | 52,065 | 0 | 54,064 | 0 | ||
| Capital Gains Distributions | 2019-12 | Purchase | 2020-12 | 106 | 0 | 0 | 106 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| AT&T | 63,754 | 57,520 |
| Abbvie Inc | 70,215 | 107,150 |
| BP PLC | 39,435 | 20,520 |
| Citigroup | 43,296 | 43,162 |
| Citizen's Finl | 0 | 0 |
| Eastern Bankshares | 24,132 | 32,620 |
| General Motors | 33,615 | 41,640 |
| Glaxo Simth Kline | 41,653 | 36,800 |
| Horizon Technology Fin Corp | 26,117 | 26,480 |
| Independent Bancorp | 16,362 | 51,128 |
| Prudential Final | 53,432 | 78,070 |
| Vector Group Ltd | 10,617 | 9,786 |
| W P Carey | 0 | 0 |
| Goldman Sachs Pfd | 9,655 | 12,290 |
| Blackrock Health Sciences TR II | 20,000 | 28,650 |
| Nuveen Build Amer Bd Fd | 50,080 | 59,375 |
| PIMCO Govt Money Mkt | 0 | 0 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| BP PLC Adr Fee | 20 | 20 | 0 | 0 |
| Glaxo Smith Kline Adr Fee | 30 | 30 | 0 | 0 |
| MA Atty General | 54 | 54 | 0 | 0 |
| Oppenheimer Fee | 75 | 75 | 0 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| US 2019 Tax Refund | 81 | 81 | 0 |
| Description | Amount |
|---|---|
| Rounding errors | 1 |